Houghton Mifflin Harcourt Company (HMHC): Corp. News News

HMHC – Company to divest its Riverside clinical and standardized testing portfolio to Alpine Investors for $140 mln.


Key Facts Surrounding This News Item


  • HMHC had a POWR Rating of D (Sell) coming into today.
  • HMHC was -2.68% below its 10-Day Moving Average coming into today.
  • HMHC was -2.68% below its 20-Day Moving Average coming into today.
  • HMHC was -9.86% below its 50-Day Moving Average coming into today.
  • HMHC was -12.54% below its 100-Day Moving Average coming into today.
  • HMHC was -20.51% below its 200-Day Moving Average coming into today.
  • HMHC had returned -35.48% year-to-date leading up to today’s news, versus a +9.24% return from the benchmark S&P 500 during the same period.

More Info About Houghton Mifflin Harcourt Company (HMHC)


Houghton Mifflin Harcourt Company provides education solutions for educational institutions and consumers worldwide. The company operates in two segments, Education and Trade Publishing. The company was established in 2013 and is based in Boston, Massachusetts. View our full HMHC ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

HMHC at a Glance

HMHC Current POWR Rating™
Overall POWR Rating™
HMHC Current Price $7.20 4.64%
More HMHC Ratings, Data, and News

HMHC Price Reaction

The day of this event (Sep. 12, 2018)
HMHC Closing Price$5.85 2.50%
HMHC Volume882,800
20.12% from avg
Leading up to this event
HMHC 1-mo returnN/A%
After this event
HMHC 1-day return9.77%
HMHC 3-day return16.08%
HMHC 5-day return19.46%

HMHC Price Chart



More Houghton Mifflin Harcourt Company (HMHC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All HMHC News
Page generated in 0.8366 seconds.